Denali Therapeutics Inc (DNLI)

Nov 16, 2024

Denali Therapeutics (NASDAQ:DNLI) Trading Down 8.3%Here's What Happened - MarketBeat

Nov 16, 2024

Nov 16, 2024

Denali Has A Neurodegenerative Edge Despite Market Skepticism (NASDAQ:DNLI) - Seeking Alpha

Nov 16, 2024

Nov 16, 2024

Los Angeles Capital Management LLC Trims Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat

Nov 16, 2024

Nov 15, 2024

We're Hopeful That Denali Therapeutics (NASDAQ:DNLI) Will Use Its Cash Wisely - Yahoo Finance

Nov 15, 2024

Nov 15, 2024

State of New Jersey Common Pension Fund D Sells 25,613 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat

Nov 15, 2024

Nov 13, 2024

Capital Research Global Investors Expands Stake in Denali Therap - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

FMR LLC Expands Stake in Denali Therapeutics Inc - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

BofA raises Denali Therapeutics target to $34 on BLA plans By Investing.com - Investing.com Canada

Nov 12, 2024

Nov 12, 2024

Denali Therapeutics executive sells shares worth $465,286 By Investing.com - Investing.com Australia

Nov 12, 2024

Nov 12, 2024

Denali Therapeutics executive sells shares worth $465,286 - Investing.com

Nov 12, 2024

Nov 12, 2024

Baillie Gifford & Co. Sells 417,709 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat

Nov 12, 2024

Nov 12, 2024

Principal Financial Group Inc. Increases Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat

Nov 12, 2024

Nov 11, 2024

Denali Therapeutics stock soars to 52-week high of $32.17 - Investing.com India

Nov 11, 2024

Nov 11, 2024

Denali Therapeutics stock soars to 52-week high of $32.17 By Investing.com - Investing.com Canada

Nov 11, 2024

Nov 11, 2024

Learn to Evaluate (DNLI) using the Charts - Stock Traders Daily

Nov 11, 2024

Nov 11, 2024

Denali Therapeutics (NASDAQ:DNLI) Reaches New 12-Month HighStill a Buy? - MarketBeat

Nov 11, 2024

Nov 11, 2024

Wedbush Cuts Earnings Estimates for Denali Therapeutics - Defense World

Nov 11, 2024

Nov 11, 2024

Brokers Issue Forecasts for DNLI Q1 Earnings - MarketBeat

Nov 11, 2024

Nov 11, 2024

HC Wainwright Has Bearish Forecast for DNLI FY2024 Earnings - MarketBeat

Nov 11, 2024

Nov 11, 2024

Equities Analysts Offer Predictions for DNLI FY2024 Earnings - MarketBeat

Nov 11, 2024

Nov 08, 2024

Wellington Management Group LLP's Strategic Acquisition in Denal - GuruFocus.com

Nov 08, 2024

Nov 08, 2024

Denali Q3 Earnings Miss Estimates, Pipeline Progress Encouraging - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

HC Wainwright Issues Pessimistic Forecast for DNLI Earnings - MarketBeat

Nov 08, 2024

Nov 07, 2024

Denali Therapeutics (NASDAQ:DNLI) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat

Nov 07, 2024

Nov 07, 2024

Denali Therapeutics (NASDAQ:DNLI) Given "Buy" Rating at HC Wainwright - MarketBeat

Nov 07, 2024

Nov 06, 2024

Denali Therapeutics earnings missed by $0.03, revenue topped estimates - Investing.com UK

Nov 06, 2024

Nov 06, 2024

Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire

Nov 06, 2024

Nov 06, 2024

Denali Therapeutics director Vicki Sato sells $83,375 in stock - Investing.com India

Nov 06, 2024

Nov 02, 2024

abrdn plc Sells 209,356 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat

Nov 02, 2024

Nov 01, 2024

Denali Therapeutics (NASDAQ:DNLI) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - MarketBeat

Nov 01, 2024

Nov 01, 2024

Thinking about buying stock in QuickLogic, Ventyx Biosciences, D - GuruFocus.com

Nov 01, 2024

Oct 29, 2024

Denali Therapeutics Inc. (DNLI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Yahoo Finance

Oct 29, 2024

Oct 27, 2024

Denali Therapeutics Inc. (NASDAQ:DNLI) Receives $38.22 Average Price Target from Analysts - MarketBeat

Oct 27, 2024

Oct 25, 2024

Zacks Research Issues Pessimistic Forecast for DNLI Earnings - MarketBeat

Oct 25, 2024

Oct 22, 2024

Denali Therapeutics CEO Ryan Watts sells shares worth $1.1 million - Investing.com

Oct 22, 2024

Oct 22, 2024

Insider Selling: Denali Therapeutics Inc. (NASDAQ:DNLI) CEO Sells 40,000 Shares of Stock - MarketBeat

Oct 22, 2024

Oct 21, 2024

(DNLI) Investment Analysis and Advice - Stock Traders Daily

Oct 21, 2024

Oct 17, 2024

The five-year returns have been notable for Denali Therapeutics (NASDAQ:DNLI) shareholders despite underlying losses increasing - Simply Wall St

Oct 17, 2024

Oct 16, 2024

Denali Therapeutics Inc (DNLI) stock on the rise: An overview - US Post News

Oct 16, 2024

Oct 15, 2024

Denali Therapeutics Inc (DNLI)’s Market Momentum: Closing Strong at 26.83, Down -4.18 - The Dwinnex

Oct 15, 2024

Oct 15, 2024

This trade activity should not be overlooked: Denali Therapeutics Inc (DNLI) - SETE News

Oct 15, 2024

Oct 15, 2024

Denali Therapeutics Inc (DNLI) receives a Mkt perform rating from Raymond James - Knox Daily

Oct 15, 2024

Oct 15, 2024

Denali Therapeutics (NASDAQ:DNLI) Price Target Lowered to $28.00 at JPMorgan Chase & Co. - Defense World

Oct 15, 2024

Oct 15, 2024

Hunter Syndrome Therapeutic Market Is in Huge Demand:Takeda, Denali Therapeutics, ArmaGen, Inventiva, Green Cross Corp, – IndiaPolitics.com - IndiaPolitics.com

Oct 15, 2024

Oct 14, 2024

Denali Therapeutics shares hold steady from BTIG By Investing.com - Investing.com South Africa

Oct 14, 2024

Oct 14, 2024

Denali Therapeutics (NASDAQ:DNLI) Shares Down 3.8% on Analyst Downgrade - MarketBeat

Oct 14, 2024

Oct 13, 2024

Denali Therapeutics Inc. (DNLI): Jeff Bezos Is Buying This Stock Now - Insider Monkey

Oct 13, 2024

Oct 13, 2024

Denali Therapeutics Inc. (NASDAQ:DNLI) Short Interest Update - MarketBeat

Oct 13, 2024

Oct 11, 2024

Denali Therapeutics (NASDAQ:DNLI) Trading 6.4% HigherTime to Buy? - MarketBeat

Oct 11, 2024

Oct 11, 2024

Sanofi, Denali face trial setback for neuro drug (NASDAQ:DNLI) - Seeking Alpha

Oct 11, 2024

Oct 11, 2024

JPMorgan Chase & Co. Cuts Denali Therapeutics (NASDAQ:DNLI) Price Target to $28.00 - MarketBeat

Oct 11, 2024

Oct 11, 2024

Denali Therapeutics Inc [DNLI] Director makes an insider purchase of 30,000 shares worth 0.87 million. - Knox Daily

Oct 11, 2024